Top Cat Choice
Menu

Nutrition

Cat Supplements: What the Evidence Actually Says

Omega-3, glucosamine, probiotics, L-lysine, taurine, vitamin B12, SAMe. What veterinary clinical evidence says about each feline supplement and when it genuinely makes sense.

The market for feline nutritional supplements in the US represents a significant and growing portion of the broader pet supplement category. A meaningful share of that spending goes toward products without robust clinical evidence. Veterinary evidence is highly uneven across supplements: for some (omega-3 in chronic kidney disease, lysine in feline herpesvirus) there are clinical trials with clear results. For others (probiotics in idiopathic cystitis, SAMe in hepatic lipidosis), the data are limited or conflicting.

This review is ordered by established clinical utility, not alphabetically.

Omega-3 (EPA + DHA): The Feline Supplement with the Most Evidence

Omega-3 fatty acids EPA and DHA, found in fish oil, have robust clinical evidence in cats for three conditions.

Feline Chronic Kidney Disease (CKD)

Omega-3 at therapeutic doses (40-60 mg/kg/day of combined EPA+DHA) reduces the progression of renal damage in cats with CKD at IRIS stages 2-3. The mechanism involves anti-inflammatory effects at the glomerular level and reduced intraglomerular hypertension. Standard veterinary practice includes omega-3 as a complement to the feline renal diet (Bauer, 2011).

Feline Osteoarthritis

Feline osteoarthritis affects 70-90% of cats over 12 years of age, though the condition is underdiagnosed because cats rarely limp visibly the way other species do. Typical signs include reduced jumping height, avoidance of stairs, and decreased self-grooming (Lascelles et al., 2010).

Omega-3 at 50-100 mg/kg/day of EPA+DHA reduces signs of arthritis in senior cats. Combined with environmental management (ramps, raised food bowls, low-entry litter boxes), this is the most cost-effective intervention for feline osteoarthritis.

Feline Allergic Dermatitis

Improves the cutaneous omega-6/omega-3 ratio. Modest usefulness as a co-treatment.

Product and dose: Liquid wild salmon oil (not capsules; difficult to administer to cats), 0.5-1 ml/day for a 9 lb (4 kg) cat, mixed into food. Products include Nordic Naturals Cat Liquid and Cosequin Joint and Skin Omega-3 Cat. Refrigerate after opening.

L-Lysine: The Open Controversy in Feline Herpesvirus

Feline herpesvirus type 1 (FHV-1) is present in a high proportion of cats: once infected, they carry the virus for life with stress-triggered reactivations. Signs include recurrent rhinotracheitis and chronic conjunctivitis.

L-lysine was proposed to compete with L-arginine for incorporation into viral proteins during FHV-1 replication (Maggs et al., 2003 demonstrated this in cell culture). The clinical translation is far less clear:

  • Early studies in shelter cats showed reduced respiratory signs with supplementation.
  • Later studies in private homes did not replicate the effect.
  • Some studies suggest long-term supplementation may increase recurrences through paradoxical mechanisms.

Current clinical position (2026): the balance between positive and negative studies is unfavorable to routine supplementation. ISFM no longer recommends it as standard management of feline FHV-1.

If used: 250-500 mg/day orally in an adult cat during reactivation episodes, not as chronic preventive supplementation.

Feline Probiotics: Selective Usefulness

Suchodolski (2016) documented intestinal dysbiosis in cats with various digestive conditions. Feline probiotics may be useful in specific situations.

Post-Antibiotic Acute Diarrhea

Enterococcus faecium SF68 (Purina Pro Plan FortiFlora Cat) has reasonable evidence. Dose: 1 sachet per day for 7-14 days during or after an antibiotic course.

Stabilized Feline Inflammatory Bowel Disease (IBD)

As a co-treatment. Saccharomyces boulardii may help. It does not replace the primary treatment.

Feline Idiopathic Cystitis

Weak evidence for oral probiotics in idiopathic cystitis (whose mechanism is neuroendocrine, not microbiological). If a urinary diet and environmental management do not resolve the condition, a co-treatment can be considered.

Where Probiotics Do Not Help

Rishniw and Wynn (2011) showed that the synbiotic Azodyl (an oral probiotic marketed to delay the progression of feline CKD) did not alter renal markers. Other commercial products making similar claims lack robust clinical evidence. They do not replace a specific renal diet or medication.

Glucosamine and Chondroitin: Modest Usefulness

Joint supplements combining glucosamine, chondroitin, and hyaluronic acid have weaker evidence in cats than in other species. Veterinary clinical practice includes them in multimodal management of feline osteoarthritis, but the individual evidence for glucosamine is modest.

For feline osteoarthritis, the combination that does have evidence:

  1. Omega-3 (high evidence).
  2. Environmental management (ramps, raised food bowls, low-entry litter boxes).
  3. Weight loss if overweight (the single largest progression factor).
  4. Glucosamine/chondroitin (Cosequin DS, Synoquin Cat) as a modest co-treatment.
  5. Veterinary anti-inflammatories (feline-dose meloxicam) under supervision when the above measures are insufficient.

Vitamin B12 (Cobalamin): Specific to Malabsorption

Recommended in cats with:

  • Inflammatory bowel disease (IBD) with low B12 on bloodwork.
  • Feline exocrine pancreatic insufficiency (EPI).
  • Feline hyperthyroidism with associated malabsorption.
  • Advanced chronic kidney disease.

Form: Weekly-to-monthly subcutaneous injection (more effective than oral supplementation in malabsorption conditions). Typical dose: 250 mcg/week for 4 weeks, then monthly.

Not useful as a preventive supplement in a healthy cat eating a complete commercial diet (B12 levels are already adequate).

Taurine: Only in Specific Cases

Any complete commercial feline diet provides taurine above the AAFCO minimum. Additional taurine supplementation in a cat eating commercial food is unnecessary.

Where supplementation may make sense:

  • A cat on a homemade diet not validated by a veterinary nutritionist (better option: switch to a nutritionally formulated homemade diet or a commercial food).
  • A cat with diagnosed taurine-responsive dilated cardiomyopathy under cardiologist supervision.
  • Breeds with documented susceptibility (Maine Coon, Ragdoll).

SAMe (S-Adenosylmethionine): Hepatoprotectant with Partial Evidence

Indicated in:

  • Feline hepatopathy (cholangiohepatitis, hepatic lipidosis post-resolution, chronic hepatitis).
  • Co-treatment in active hepatic toxicity (acetaminophen, hepatotoxic plants).

Product: Denamarin Cat (Nutramax). Dose: 200-400 mg/day.

Useful under veterinary prescription. There is no rationale for preventive supplementation in a healthy cat.

L-Carnitine: Usefulness in Weight-Loss Programs

A cofactor in lipid oxidation. Some weight-management cat foods already include it in their formulation (Hill's Metabolic, Royal Canin Satiety). Additional supplementation with commercial tablets rarely adds anything beyond what a well-formulated food already provides.

Vitamin E and Selenium: Antioxidants in Specific Conditions

Indicated only in:

  • Feline steatitis (severe deficiency from excess oily fish in the diet).
  • Chronic feline pancreatitis as a co-treatment.

Do not supplement preventively. Excess carries a toxicity risk (vitamin E hypervitaminosis).

Catnip: Enrichment, Not Nutrition

The nepetalactone in Nepeta cataria produces a transient psychoactive response in approximately 60-70% of cats. No known adverse effects. Useful for environmental enrichment, not as nutrition.

Supplements with No Clear Evidence or Evidence Against

  • Feline CBD: The FDA-CVM has not approved any CBD product for cats and notes limited safety data in felines. Published controlled trials in cats are absent.
  • Nutritional yeast as a B-vitamin source: Provides B vitamins but also purines (a urate risk factor in predisposed males).
  • Echinacea for "immune support": No veterinary clinical evidence in cats.
  • Turmeric for feline arthritis: Very limited evidence. Possible interactions with anti-inflammatories.
  • Coconut oil: Over-promoted on social media. No documented feline benefit; high-fat supplementation at meaningful doses risks pancreatitis.
  • Wormwood or garlic as "natural antiparasitics": Directly dangerous for cats.

Practical Rules for Feline Supplementation

  1. A complete commercial food covers the essentials. Most healthy cats eating a quality diet need no supplements.
  2. Supplements do not replace the right base diet. If the base diet is poor, supplementing does not fix the problem.
  3. Each supplement needs a clear clinical indication. Supplementing "just in case" has no justifiable cost-benefit ratio.
  4. Consult a veterinarian before combining multiple supplements. Documented interactions include: omega-3 with certain anti-inflammatories; SAMe with some medications; excess antioxidants that paradoxically become pro-oxidant.
  5. Calculate the cost-benefit. A supplement costing $25/month to "improve coat" in a cat with healthy coat and premium food adds nothing demonstrable.

For cats without diagnosed disease, the one area where a modest precautionary argument can be made: omega-3 starting around age 8-10 to slow subclinical joint and renal deterioration. For everything else, a specific clinical indication should come first.

Sources

  • Bauer, J. E. (2011). Therapeutic use of fish oils in companion animals. JAVMA
  • Lascelles, B. D. X. et al. (2010). Cross-sectional study evaluating the association of pet ownership and lifestyle. Veterinary Surgery
  • Maggs, D. J. et al. (2003). Effects of L-lysine and L-arginine on in vitro replication of feline herpesvirus type-1. AJVR
  • Rishniw, M. & Wynn, S. G. (2011). Azodyl, a synbiotic, fails to alter azotemia in cats with chronic kidney disease. Journal of Feline Medicine and Surgery
  • Suchodolski, J. S. (2016). Diagnosis and interpretation of intestinal dysbiosis. Veterinary Journal
  • Association of American Feed Control Officials (AAFCO). Official Publication 2025